Answer
Tapimio (tapentadol phosphate) is not recommended for children and adolescents under 18 because its safety and efficacy have not yet been established in this population.
Sources for this answer
- Tapimio 50 mg prolonged-release capsulesNeuraxpharm UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 1Document updated
Sources checked